New Zealand markets open in 2 hours 48 minutes

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
122.93+1.58 (+1.31%)
As of 01:11PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 267.54B
Enterprise value 265.93B
Trailing P/E 36.62
Forward P/E 27.86
PEG ratio (5-yr expected) 1.81
Price/sales (ttm)11.58
Price/book (mrq)24.93
Enterprise value/revenue 1.59
Enterprise value/EBITDA 3.31

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 313.12%
S&P500 52-week change 3-12.31%
52-week high 3123.93
52-week low 391.51
50-day moving average 3107.91
200-day moving average 3108.52

Share statistics

Avg vol (3-month) 31.41M
Avg vol (10-day) 31.17M
Shares outstanding 52.25B
Implied shares outstanding 6N/A
Float 81.61B
% held by insiders 10.01%
% held by institutions 18.36%
Shares short (14 Nov 2022) 42.62M
Short ratio (14 Nov 2022) 41.79
Short % of float (14 Nov 2022) 4N/A
Short % of shares outstanding (14 Nov 2022) 40.12%
Shares short (prior month 13 Oct 2022) 43.22M

Dividends & splits

Forward annual dividend rate 41.6
Forward annual dividend yield 41.32%
Trailing annual dividend rate 311.15
Trailing annual dividend yield 39.19%
5-year average dividend yield 42.05
Payout ratio 447.89%
Dividend date 322 Aug 2022
Ex-dividend date 411 Aug 2022
Last split factor 25:1
Last split date 308 Jan 2014

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 31.60%
Operating margin (ttm)43.10%

Management effectiveness

Return on assets (ttm)21.60%
Return on equity (ttm)73.99%

Income statement

Revenue (ttm)167.2B
Revenue per share (ttm)73.57
Quarterly revenue growth (yoy)27.90%
Gross profit (ttm)117.14B
Net income avi to common (ttm)52.83B
Diluted EPS (ttm)3.22
Quarterly earnings growth (yoy)18.90%

Balance sheet

Total cash (mrq)37.47B
Total cash per share (mrq)16.57
Total debt (mrq)25.97B
Total debt/equity (mrq)33.87
Current ratio (mrq)0.92
Book value per share (mrq)33.90

Cash flow statement

Operating cash flow (ttm)68.77B
Levered free cash flow (ttm)56.95B